Oreste Davide Gentilini M.D. Personal Details Place of Birth: Milan Date of Birth: 07/04/1968 Citizenship: Italian Languages: Italian (mother tongue), English (excellent), Spanish (good) Status: Married with Arianna, We have two children: Davide 9 years and Marlene 7 years Current position Since April 2007 Deputy-Director of Breast Surgery of the European Institute of Oncology, Milano, Italy Since 2012 Principal Investigator of the prospective randomized trial IEO S637/311 (Propective randomized trial comparing sentinel node biopsy vs no axillary surgical staging in patients with small breast cancer and a negative pre-operative axillary assessment. Trial SOUND: Sentinel node vs Observation after axillary Ultra-souND) Education and training 2012 first classified at the selection for Head of the General Breast Surgery Division of the Santarcangelo-Rimini Hospital (declined) Since 2001 attending of the staff of the Breast Surgery Division of the European Institute of Oncology. In 2000 fellow of the General Surgery Department of the S. Raffaele Hospital in Milano. In 1999 completion of the residency program in General Surgery in Milano (70/70 cum laude 1996-1997 research fellow of the New York Hospital-Cornell Medical Center focusing on nutrition in oncology and immuno-biology of tumors (Chairman Dr. John M. Daly) 1993 Graduation at the University of Milano (110/110 cum laude). Clinical and Research Activities As operating surgeon I personally performed approximately 3500 breast operations with about 1300-1400 visits per year. My efforts regarding clinical research have been focused in sentinel lymph node biopsy, intraoperative radiotherapy, and in the possibility of extending breast conservation in special clinical scenario such as multifocal-multicentric breast cancer, in patients with local reappearance or after primary medical treatment. One of my favourite interests is the study of breast cancer diagnosed in young women or during pregnancy and in field of fertility preservation. As Principal Investigator of the SOUND trial (Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast. 2012 Oct;21(5):678-81. doi: 10.1016/j.breast.2012.06.013. Epub 2012 Jul 25) I am currently involved in establishing partnership with the about 20 italian centers and 15 international institutes which showed concrete interest in joining our prospective randomized trial.
© Copyright 2024 ExpyDoc
